Cardiac Function in Pre-Clinical Diabetic Diastolic Heart Failure Subjects …MarketWatch (press release)Dr. Tschöpe is also a member of the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology. "…
BG Medicine, Inc. Obtains CE Mark and Files 510(k) for Expanded BGM Galectin-3 …MarketWatch (press release)The blood test was cleared by the FDA in November 2010 and is currently indicated for use in patients with chronic heart failure who are at inc…
TheChronicleHerald.caKidney disease is a leading killer in catsnwitimes.comOne in 12 older cats has chronic kidney disease, according to Banfield Pet Hospital's just-released 2012 State of Pet Health Report. Banfield, the largest veterinary practic…
BG Medicine Publishes Study On Use Of Galectin-3 In Drug Therapy In HeartFailureNASDAQ(RTTNews.com) – BG Medicine Inc. (BGMD) announced that results from a sub-study of the Controlled Rosuvastatin Multinational Trial in Heart Failure or CORONA trial we…
BioVentrix Selected to Present at Prestigious EuroPCR MeetingReutersPARIS–(Marketwire – May 14, 2012) – BioVentrix, the developer of minimally invasive therapies for the treatment of heart failure, was selected to present at EuroPCR, the annual meetin…
BG Medicine Announces Publication of First Study on Use of Galectin-3 in …MarketWatch (press release)The galectin-3 CORONA study was designed to assess whether baseline galectin-3 levels could distinguish a group of patients with heart failure who wo…
Differences in regional readmission rates for heart failure tied to …News-Medical.netDifferences in regional hospital readmission rates for heart failure are more closely tied to the availability of care and socioeconomics than to hospital performanc…
CRT-D cost-effective treatment for mildly symptomatic heart failure patientsNews-Medical.netMedtronic, Inc. (NYSE: MDT) today announced findings from an economic analysis of the landmark RAFT (Resynchronization / Defibrillation in Ambulatory Heart Fail…
'Enhanced' Stem Cells Improve HF OutcomesMedPage TodayA heart failure patient's bone marrow stem cells, enhanced to increase the number of immune cells, can improve functional capacity and reduce adverse events when delivered back into the …
CBS LocalStudy Finds Race Not Factor In Standard Heart Failure TreatmentCBS LocalDETROIT (WWJ) – A traditional treatment for heart failure appears to be equally protective in preventing death or hospitalization among African-American patients, as com…